Search results
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 9 hours agoWith support from Sanofi's army of regulatory process experts and a global sales team with heaps of ...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
FOX 4 Kansas City· 4 days ago...Agreements and in India, Japan and South Korea where Novavax has existing partnership agreements); a sole license to Novavax's adjuvanted COVID-19 vaccine for use in combination with Sanofi's flu vaccines while Novavax retains the right to and is developing its own COVID-19-Influenza Combination ...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi By Investing.com
Investing.com· 2 days agovaccine market leadership to commercialize its Nuvaxovid vaccine in the U.S., U.K., and Europe. ...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga via Yahoo Finance· 4 days agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
Novavax's Q1 Results Are Overshadowed by Its Sanofi Partnership | The Motley Fool
The Motley Fool· 1 day agoNovavax (NVAX 47.63%) released its first-quarter earnings report on May 10, and the vaccine-focused biotechnology company's numbers reflected notable progress ...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
FOX 23 News Albany· 4 days agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop ...
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 1 day agoJust when the Covid-vaccine maker Novavax Inc.'s (NVAX) future as a going concern seemed uncertain, a remarkable turnaround has unfolded, thanks to the ...